Abstract：【Objective】To investigate the clinical efficacy of sequential chemoradiotherapy and concurrent chemoradiotherapy in the treatment of advanced gastric cancer.【Methods】 One hundred and sixty patients with gastric cancer after radical operation were randomly divided into two groups, the observation group was treated with adjuvant chemotherapy after the 4 cycles of intensity modulated radiation therapy, the control group was treated with radiotherapy and chemotherapy at the same time, the efficacy of the two groups were compared between the two groups.【Results】The survival rate of the observation group was 87.50%, 76.25%,53.75%(43/80) respectively, which were significantly higher than those in the control group (73.75%, 60%,37.50%) (P<0.05);There was no significant difference in the incidence of complications such as fever, gastrointestinal reaction, liver and kidney dysfunction in the observation group compared with the control group (P>0.05). In the observation group, the recurrence rate was 26.25% (21/80), which was significantly lower than that in the control group (40/80), and the difference was significant (P<0.05).【Conclusion】In the treatment of advanced gastric cancer, sequential radiotherapy is more effective than the concurrent radiotherapy and chemotherapy, and the recurrence rate is low, so it is worthy of popularization and application.
林晓明;梁荣;李淑慧;陈兴贵;易小琼;张英;. 序贯放化疗与同期放化疗治疗进展期胃癌的临床疗效比较[J]. 医学临床研究, 2017, 34(4): 680-681.
LIN Xiao-ming, LIANG Rong, LI Shu-hui,et al . Clinical Efficacy of Sequential Chemoradiotherapy and Concurrent Chemoradiotherapy in the Treatment of Advanced Gastric Cancer. JOURNAL OF CLINICAL RESEARCH, 2017, 34(4): 680-681.
[1] 马耀先.恩度与化疗联合治疗晚期消化道肿瘤的临床疗效[J].中国老年学杂志,2014,34(14):4065-4066. [2] Fen X, Qin W, Bao W,et al. Arterial interventional chemotherapy and IMRT with concurrent chemotherapy for nasopharyngeal carcinoma with intracranial involvement[J].Oncol Lett,2013, 6(2): 427-431. [3] Lammers T, Kiessling F, Hennink W E, et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress[J].J Controll Release,2012, 161(2): 175-187. [4] Selzer E. Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments[J].Exp Rev Clin Pharmacol,2013, 6(6): 663-676. [5] Jensen AD, Nikoghosyan AV.IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial[J].BMC Cancer,2012, 12(1): 1. [6] Moreno-Luna LE, Yang JD.Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma[J].Cardiovasc Int Radiol,2013, 36(3): 714-723. [7] 祁英,陈东基,马有国,等.吉西他滨诱导化疗后放疗同步联合卡培他滨治疗局部进展期胰腺癌的临床疗效[J].中华放射医学与防护杂志,2014,34(5):355-357. (本文编辑:王沪湘) [收稿日期] 2016-10-20
2017, Vol. 34 
